Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Sep 27:16:4393-4404.
doi: 10.2147/IJGM.S423910. eCollection 2023.

Severe, Persistent, Disruptive Fatigue Post-SARS-CoV-2 Disproportionately Affects Young Women

Affiliations

Severe, Persistent, Disruptive Fatigue Post-SARS-CoV-2 Disproportionately Affects Young Women

Jillian Kallman Price et al. Int J Gen Med. .

Abstract

Introduction: Post-acute SARS-CoV-2 (PASC) symptoms are often persistent, disruptive, and difficult to treat effectively. Fatigue is often among the most frequently reported symptoms and may indicate a more challenging road to recovery.

Purpose: To describe the natural history, symptomology, and risk profile of long-term post-acute SARS-CoV-2.

Patients and methods: Participants treated for SARS-CoV-2 within a large, community health system in the US were enrolled prospectively in a longitudinal, observational PASC study examining participants at enrollment and 6 months. Medical history, symptom reporting, validated measures of cognition, and patient-reported outcomes (PROs), were performed for all participants and repeated during study follow-up visits.

Results: A total of 323 participants completed baseline evaluations. Sixty one participants indicated clinically significant fatigue (23.1% at baseline); a representative sample of 141 enrollees also completed a baseline Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F) in-depth fatigue reporting questionnaire, 37 had severe fatigue. The severely fatigued (FACIT-F ≤29.7) were significantly younger, female, had more anxiety and depression, had a higher resting heart rate, reported more sick days, and were less physically active post-COVID. They were more likely to have a diagnosis of chronic kidney disease (13.5% vs 2.9%) but less likely to have a history of cancer (8.1% vs 23.1). Participants who were severely fatigued reported health, diet, weight, and sleep were worse than those not severely fatigued post-COVID (p = 0.02 to 0.0002). Fatigue was significantly correlated with impairment of all PROs administered after COVID-19 infection.

Conclusion: Fatigue is a common symptom post-COVID-19 infection and is associated with lower reported well-being and function. Those with severe fatigue tended to be younger and female and have a past medical history of anxiety, depression, kidney disease, and more sedentary lifestyles.

Keywords: COVID-19; FACIT-F; SARS-CoV-2; functional assessment of chronic illness therapy-fatigue; recovery; symptom severity.

PubMed Disclaimer

Conflict of interest statement

In addition to the internal funding received for this study reported in acknowledgements, some authors have received funding for other research endeavors. Specifically, AAW cites institutional payments by the Health Resources and Services Administration (HRSA), and ZMY has consulted for Bristol Myers Squibb, Gilead, Intercept, Novo Nordisk, Novartis, Terns, Merck, Quest, and Siemens, and Madrigal. The authors declare that they have no other competing interests in this work.

Figures

Figure 1
Figure 1
Symptom Reporting Categorization.
Figure 2
Figure 2
Percentage of patients with severe fatigue among all those completing the Functional Assessment of Chronic Illness Therapy - Fatigue (FACIT-F).
Figure 3
Figure 3
Percentage of participants with severe fatigue at baseline by self-reported symptoms.
Figure 4
Figure 4
6-month symptoms frequency in the severely fatigued per Functional Assessment of Chronic Illness Therapy - Fatigue (FACIT-F).

References

    1. Ledford H. How common is long COVID? Why studies give different answers. Nature. 2022;606(7916):852–853. doi: 10.1038/d41586-022-01702-2 - DOI - PubMed
    1. Kamal M, Abo Omirah M, Hussein A, Saeed H. Assessment and characterization of post-COVID-19 manifestations. Int J Clin Pract. 2021;75(3):e13746. doi: 10.1111/ijcp.13746 - DOI - PMC - PubMed
    1. Carter SJ, Baranauskas MN, Raglin JS, Pescosolido BA, Perry BL. Functional status, mood state, and physical activity among women with post-acute COVID-19 syndrome. Int J Public Health. 2022;67:1604589. doi: 10.3389/ijph.2022.1604589 - DOI - PMC - PubMed
    1. Munipalli B, Seim L, Dawson NL, Knight D, Dabrh AMA. Post-acute sequelae of COVID-19 (PASC): a meta-narrative review of pathophysiology, prevalence, and management. SN Compr Clin Med. 2022;4(1):90. doi: 10.1007/s42399-022-01167-4 - DOI - PMC - PubMed
    1. Chippa V, Aleem A, Anjum F. Post-Acute Coronavirus (COVID-19) Syndrome. Treasure Island (FL): StatPearls Publishing; 2023. - PubMed